Impact of a Pure Reduction in Heart Rate for the Treatment of Left Ventricular Dysfunction: Clinical Benefits of Ivabradine in the BEAUTIFUL Trial
Thérapie, 64 2 (2009) 111-114
Published online: 2009-08-11
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Pharmacological interventions for heart failure in people with chronic kidney disease
Meaghan Lunney, Marinella Ruospo, Patrizia Natale, Robert R Quinn, Paul E Ronksley, Ioannis Konstantinidis, Suetonia C Palmer, Marcello Tonelli, Giovanni FM Strippoli and Pietro RavaniCochrane Database of Systematic Reviews 2020 (2) (2020)
https://doi.org/10.1002/14651858.CD012466.pub2
New pharmacological treatments for heart failure with reduced ejection fraction (HFrEF)
Heng Li, Yuting Duan, Benfa Chen, Yu Zhao, Weiping Su, Shanhua Wang, Jiaming Wu and Liming LuMedicine 99 (5) e18341 (2020)
https://doi.org/10.1097/MD.0000000000018341
Comparison Study of Effect of Ivabradine versus Beta Blockers in Early Management of Acute Coronary Syndrome with Left Ventricular Systolic Dysfunction in a Tertiary Care Hospital of West Bengal
Mausumi De, Amit Kumar Ghosh, Uday Sankar Das, Saugata Ghosh and Subhajit PaulJournal of Evidence Based Medicine and Healthcare 6 (49) 3092 (2019)
https://doi.org/10.18410/jebmh/2019/647